Management of fever in neutropenic adult patients with cancer (notice n° 174428)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02100cam a2200301 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112035912.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Baldeyrou, Marion |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Management of fever in neutropenic adult patients with cancer |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2019.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 90 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Although less frequent and severe than in a hematological setting, febrile neutropenia (FN) is one of the most feared complications following chemotherapy for solid cancer. Its management must be systematic: i) early detection of life-threatening organ dysfunction; ii) full history and physical examination to identify the site of infection, and a blood culture test carried out; iii) administration of the first dose of empirical antibiotherapy within the first hour after initial presentation; iv) identification of patients suitable for outpatient management. An oral fluoroquinolone plus amoxicillin/clavulanate is recommended as empirical outpatient treatment. Different types of antibiotic treatments are recommended for hospitalized patients, depending on the patient in question's clinical presentation. Whether they are hospitalized or not, a patient's clinical condition must be reassessed regularly in order to adjust the antimicrobial therapy if they remain febrile. Thanks to this systematic approach, patients with NF receive treatment that is perfectly safe and as unrestrictive as possible, and may even be able to receive the treatment as outpatients. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | solid cancer |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | febrile neutropenia |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | management |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | chemotherapy |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | solid cancer |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | febrile neutropenia |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | management |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | chemotherapy |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Le Bot, Audrey |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Limonta, Silvia |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tattevin, Pierre |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Revest, Matthieu |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Hépato-Gastro & Oncologie Digestive | 26 | HS1 | 2019-10-01 | p. 34-40 | 2115-3310 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-hepato-gastro-et-oncologie-digestive-2019-HS1-page-34?lang=en">https://shs.cairn.info/journal-hepato-gastro-et-oncologie-digestive-2019-HS1-page-34?lang=en</a> |
Pas d'exemplaire disponible.
Réseaux sociaux